Pfizer to sell about $3.25 billion stake in Sensodyne-maker Haleon, bookrunner says
Pfizer's stake sale in British consumer healthcare company Haleon has been upsized by 100 million shares to 640 million shares worth about $3.25 billion with strong demand from investors, a bookrunner familiar with the offering said on Monday.
Pfizer to Pare Back Haleon Stake With 540 Million Share Offering
Pfizer Inc. plans to sell 540 million worth of shares in Haleon Plc, as it pares back its holding in the UK consumer health giant.
Pfizer to Offload About 5.9% Stake in UK's Haleon, Says Bookrunner
(Reuters) - Pfizer intends to offload about 540 million shares in the British consumer healthcare company Haleon, a bookrunner said on Monday. The proposed sale will reduce the top shareholder's interest in Sensodyne-maker Haleon to 16.2% from 22.6%.
Sensodyne maker Haleon to raise stake in China JV
(Reuters) -British consumer healthcare company Haleon said on Friday it has agreed to increase its stake in its Chinese joint venture to 88% from 55% for 4.47 billion yuan ($637.35 million). The joint venture,
TOP NEWS: Pfizer to raise around GBP2.7 billion from Haleon stake sale
On completion, Pfizer, the New York-based pharmaceuticals firm, will see its interest in Haleon fall to just over 16% from 22.6% currently. Bloomberg reported that the share sale price is likely to be 380 pence per share, raising around GBP2.7 billion.
Pfizer to sell about $3.25 bln stake in Sensodyne-maker Haleon, bookrunner says
Sept 30 (Reuters) - Pfizer's stake sale in British consumer healthcare company Haleon has been upsized by 100 million shares to 640 million shares worth about $3.25 billion with strong demand from investors, a bookrunner familiar with the offering said on Monday.
Pfizer to offload about 6% stake in Sensodyne-maker Haleon, says bookrunner
Pfizer intends to sell about 540 million shares in British consumer healthcare company Haleon, a bookrunner said on Monday, reducing the top shareholder's interest in the Sensodyne maker to 16.2%. Haleon separately said on Monday it had agreed to make an off-market purchase of about 230 million pounds ($308.
Pfizer Intends to Sell Around 540 Million Ordinary Shares in Haleon -- Update
Pfizer will receive all net proceeds from the offering, it said. In a separate statement, Haleon said it agreed to make an off-market purchase of approximately 230 million pounds ($307.7 million) worth of its ordinary shares from Pfizer.
Sensodyne Introduces All-In-One Care Toothpaste 'Sensodyne Complete Protection Plus'
Sensitive care toothpaste brand Sensodyne has launched an all-in-one care toothpaste 'Sensodyne Complete Protection Plus'.It ...
YourTango1d
Woman Shares Her Reaction To Brushing Her Teeth For The First Time In 9 Years
According to the woman, her teeth were prone to damage and breaking, making it nearly impossible for her to brush her teeth.
Best Media6d
Sensodyne celebrates #DoctorsOfJoy this World Dentist's Day
DoctorsOfJoy aims to highlight how dentists empower individuals to fully enjoy life's moments by addressing oral health ...
California enacts car data privacy law to curb domestic violence
California Governor Gavin Newsom has signed a bill that requires automakers selling internet-connected cars to do more to ...
Pfizer to Pare Haleon Stake With 540 Million Share Offering
Pfizer Inc. announced a further reduction of its stake in Haleon Plc, offering to sell about a 5.9% stake in the UK consumer ...